Suppr超能文献

危重症、已定植患者的耳念珠菌念珠菌血症:累积发病率及危险因素

Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors.

作者信息

Briano Federica, Magnasco Laura, Sepulcri Chiara, Dettori Silvia, Dentone Chiara, Mikulska Malgorzata, Ball Lorenzo, Vena Antonio, Robba Chiara, Patroniti Nicolò, Brunetti Iole, Gratarola Angelo, D'Angelo Raffaele, Di Pilato Vincenzo, Coppo Erika, Marchese Anna, Pelosi Paolo, Giacobbe Daniele Roberto, Bassetti Matteo

机构信息

Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.

Infectious Diseases Unit, San Martino Policlinico Hospital-IRCCS for Oncology and Neurosciences, L.go R. Benzi 10, 16132, Genoa, Italy.

出版信息

Infect Dis Ther. 2022 Jun;11(3):1149-1160. doi: 10.1007/s40121-022-00625-9. Epub 2022 Apr 11.

Abstract

INTRODUCTION

Candida auris (C. auris) is an emerging nosocomial pathogen, and a sharp rise in cases of colonization and infection has been registered in intensive care units (ICUs) during the ongoing coronavirus disease 2019 (COVID-19) pandemic. The unfavorable resistance profile of C. auris and the potential high mortality of C. auris infections represent an important challenge for physicians.

METHODS

We conducted a single-center retrospective study including all patients admitted to ICUs with isolation of C. auris in any non-sterile body site between February 20, 2020, and May 31, 2021. The primary aim of the study was to assess the cumulative incidence of C. auris candidemia in colonized patients. The secondary aim was to identify predictors of C. auris candidemia in the study population.

RESULTS

During the study period, 157 patients admitted to ICUs in our hospital became colonized with C. auris; 59% of them were affected by COVID-19. Overall, 27 patients (17%) developed C. auris candidemia. The cumulative risk of developing C. auris candidemia was > 25% at 60 days after first detection of C. auris colonization. Seven patients with C. auris candidemia (26%) also developed a late recurrent episode. All C. auris blood isolates during the first occurring episode were resistant to fluconazole and susceptible to echinocandins, while 15 (56%) were resistant to amphotericin B. During late recurrent episodes, emergent resistance to caspofungin and amphotericin B occurred in one case each. In the final multivariable model, only multisite colonization retained an independent association with the development of C. auris candidemia.

CONCLUSION

Candida auris candidemia may occur in up to one fourth of colonized critically ill patients, and multisite colonization is an independent risk factor for the development of candidemia. Implementing adequate infection control measures remains crucial to prevent colonization with C. auris and indirectly the subsequent development of infection.

摘要

引言

耳念珠菌是一种新出现的医院病原体,在2019年冠状病毒病(COVID-19)大流行期间,重症监护病房(ICU)中该菌的定植和感染病例急剧增加。耳念珠菌不利的耐药谱以及耳念珠菌感染潜在的高死亡率对医生构成了重大挑战。

方法

我们进行了一项单中心回顾性研究,纳入了2020年2月20日至2021年5月31日期间入住ICU且在任何非无菌身体部位分离出耳念珠菌的所有患者。该研究的主要目的是评估定植患者中耳念珠菌血症的累积发病率。次要目的是确定研究人群中耳念珠菌血症的预测因素。

结果

在研究期间,我院157例入住ICU的患者被耳念珠菌定植;其中59%的患者感染了COVID-19。总体而言,27例患者(17%)发生了耳念珠菌血症。首次检测到耳念珠菌定植后60天,发生耳念珠菌血症的累积风险>25%。7例耳念珠菌血症患者(26%)还出现了晚期复发。首次发作期间所有耳念珠菌血培养分离株均对氟康唑耐药,对棘白菌素敏感,而15株(56%)对两性霉素B耐药。在晚期复发期间,各有1例出现对卡泊芬净和两性霉素B的新发耐药。在最终的多变量模型中,只有多部位定植与耳念珠菌血症的发生保持独立关联。

结论

高达四分之一的定植危重症患者可能发生耳念珠菌血症,多部位定植是念珠菌血症发生的独立危险因素。实施适当的感染控制措施对于预防耳念珠菌定植以及间接预防随后的感染发生仍然至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81e2/9124250/c78dab70c2a9/40121_2022_625_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验